title: Use of proteins to minimize the physical aging of EUDRAGIT sustained release films.
abstract: The objective of this study was to investigate the influence of two proteins, albumin and type B gelatin, on the physical aging of EUDRAGIT RS 30 D and RL 30 D coated theophylline pellets. The physicomechanical properties of sprayed films, thermal properties of cast films, influence of proteins on the zeta potential and particle size of the dispersion, and the release of proteins from cast films under simulated dissolution conditions were investigated. The release rate of theophylline decreased significantly over time from pellets coated with an acrylic dispersion containing 10% albumin when there was no acidification of the acrylic dispersion; however, when pellets were coated with an acidified EUDRAGIT/albumin dispersion, the theophylline release rate was stable for dosage forms stored in the absence of humidity. The drug release rate was faster for pellets coated with acrylic dispersions containing 10% gelatin compared to the albumin-containing formulations. When sprayed films were stored at 40 degrees C/75% RH, the water vapor permeability decreased significantly for both EUDRAGIT films and those containing EUDRAGIT and albumin; however, there was no significant change in this parameter when 10% gelatin was present. Albumin was released from the acrylic films when the pH of the dissolution media was below the isoelectric point of the protein while no quantitative release of gelatin was observed in pH 1.2 or 7.4 media. The effect of gelatin to prevent the decrease in drug release rate was due to stabilization in water vapor permeability of the film. Acidification of the polymeric dispersion resulted in electrostatic repulsive forces between albumin and the acrylic polymer, which stabilized the drug release rate when the dosage forms were stored in aluminum induction sealed containers at both 40 degrees C/75% RH and 25 degrees C/60% RH.
authors.affiliation: Drug Dynamics Institute, College of Pharmacy, University of Texas at Austin, Austin, TX, USA. skucera@mail.utexas.edu
authors.forename: Shawn A
authors.initials: SA
authors.lastname: Kucera
authors.forename: James W
authors.initials: JW
authors.lastname: McGinity
authors.forename: Weijia
authors.initials: W
authors.lastname: Zheng
authors.forename: Navnit H
authors.initials: NH
authors.lastname: Shah
authors.forename: A Waseem
authors.initials: AW
authors.lastname: Malick
authors.forename: Martin H
authors.initials: MH
authors.lastname: Infeld
mesh_terms: D000180:Acrylic Resins / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations / Q000737:chemistry; D004355:Drug Stability; D004356:Drug Storage; D005780:Gelatin / Q000737:chemistry*; D006863:Hydrogen-Ion Concentration; D007526:Isoelectric Point; D010316:Particle Size; D011108:Polymers / Q000737:chemistry*; D012710:Serum Albumin, Bovine / Q000737:chemistry*; D012995:Solubility; D055672:Static Electricity; D013806:Theophylline / Q000737:chemistry*
chemical_list: D000180:Acrylic Resins; D003692:Delayed-Action Preparations; D011108:Polymers; D012710:Serum Albumin, Bovine; C050528:Eudragit RS; C058665:Eudragit RL; D005780:Gelatin; D013806:Theophylline